⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Mifepristone
میفپریستون
🚻 Genito Urinary System And Sex HormonesProgestin antagonist
🤰 Pregnancy:Contraindicated🤱 Breastfeeding:Use with caution👶 Children:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA020687ATC G03XB01
Market / country: 🇺🇸 USA
Mifeprex (US)
🧮 Dose calculator
Medical termination of pregnancy · Regimen source: FDA Mifeprex · 2.1
- • Remove any IUD before starting. Follow-up at 7–14 days to confirm complete termination is required. FDA Mifeprex · 2.1FDA Mifeprex · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass; IUD in place; chronic adrenal failure; long-term corticosteroid therapy; allergy to mifepristone, misoprostol or prostaglandins; haemorrhagic disorders or anticoagulant therapy; inherited porphyrias. FDA Mifeprex · 4
Warnings
- • Boxed warning: serious and sometimes fatal infections and bleeding (infection may present without fever). Available only through REMS. FDA Mifeprex · Boxed Warning
- • Does not treat ectopic pregnancy; Rh immunisation (anti-D immune globulin if Rh-negative). FDA Mifeprex · 5
Formulations
- 200 mg tablet — tablet 🇺🇸 USA FDA Mifeprex · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Mifeprex · 4
“Administration of MIFEPREX and misoprostol for the termination of pregnancy (the “treatment procedure”) is contraindicated in patients with any of the following conditions: Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass (the treatment procedure will not be effective to terminate an ectopic …”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Mifeprex · 8.2
“MIFEPREX is present in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Mifeprex · 8.4
“Safety and efficacy of MIFEPREX have been established in pregnant females.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020687
- DailyMed (FDA label)FDA Mifeprex
- MedlinePlus (NIH)Mifepristone (Korlym)Mifepristone (Mifeprex)
- WHO ATC/DDDG03XB01
- Darooyab (Iran)Mifepristone
🇮🇷 Registered in Iran Darooyab · G-3284/Mifepristone
Dosage forms with Iranian generic codes, per Darooyab.
- 12366 · MIFEPRISTON 200MG TAB · قرص میفپریستون ۲۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Mifeprex · 3FDA Mifeprex · 2.1FDA Mifeprex · 2.3FDA Mifeprex · 4FDA Mifeprex · Boxed WarningFDA Mifeprex · 5FDA Mifeprex · SPL approval / marketing categoryFDA Mifeprex · 8.2FDA Mifeprex · 8.4
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3284/Mifepristone
- Clinical review⚠ Unverified